1. Home
  2. SAMG vs IPSC Comparison

SAMG vs IPSC Comparison

Compare SAMG & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAMG
  • IPSC
  • Stock Information
  • Founded
  • SAMG 2002
  • IPSC 2019
  • Country
  • SAMG United States
  • IPSC United States
  • Employees
  • SAMG N/A
  • IPSC N/A
  • Industry
  • SAMG Investment Managers
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • SAMG Finance
  • IPSC Health Care
  • Exchange
  • SAMG Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • SAMG 171.2M
  • IPSC 149.1M
  • IPO Year
  • SAMG 2013
  • IPSC 2021
  • Fundamental
  • Price
  • SAMG $18.20
  • IPSC $1.37
  • Analyst Decision
  • SAMG
  • IPSC Strong Buy
  • Analyst Count
  • SAMG 0
  • IPSC 4
  • Target Price
  • SAMG N/A
  • IPSC $13.00
  • AVG Volume (30 Days)
  • SAMG 24.9K
  • IPSC 497.4K
  • Earning Date
  • SAMG 10-31-2024
  • IPSC 11-05-2024
  • Dividend Yield
  • SAMG 4.34%
  • IPSC N/A
  • EPS Growth
  • SAMG N/A
  • IPSC N/A
  • EPS
  • SAMG 0.79
  • IPSC N/A
  • Revenue
  • SAMG $120,231,000.00
  • IPSC $2,684,000.00
  • Revenue This Year
  • SAMG $7.10
  • IPSC $244.52
  • Revenue Next Year
  • SAMG $5.89
  • IPSC $27.73
  • P/E Ratio
  • SAMG $23.29
  • IPSC N/A
  • Revenue Growth
  • SAMG 2.45
  • IPSC 7.88
  • 52 Week Low
  • SAMG $13.93
  • IPSC $1.14
  • 52 Week High
  • SAMG $18.77
  • IPSC $5.51
  • Technical
  • Relative Strength Index (RSI)
  • SAMG 61.49
  • IPSC 40.29
  • Support Level
  • SAMG $17.74
  • IPSC $1.20
  • Resistance Level
  • SAMG $18.61
  • IPSC $1.29
  • Average True Range (ATR)
  • SAMG 0.42
  • IPSC 0.11
  • MACD
  • SAMG 0.02
  • IPSC -0.00
  • Stochastic Oscillator
  • SAMG 85.94
  • IPSC 8.75

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Share on Social Networks: